# Genus plc / PIC

a CD163-exon deletion that blocks the PRRS virus's cell-entry point; approved by the FDA on April 30, 2025, and by Health Canada and the CFIA on January 23, 2026.

Source: https://en.bioecon.ru/companies/genus-plc/
Updated: 2026-07-06

- Country: United Kingdom

## Technologies

- [Livestock genetic engineering and precision breeding](https://en.bioecon.ru/technology/livestock-gene-editing-precision-breeding/)